Using a Spike-In Experiment to Evaluate Analysis of LC-MS Data

We present a spike-in experiment to evaluate the performance of software tools in detecting differentially abundant peptides by a label-free LC-MS method. The performance of each tool is assessed by the ability to detect and pick spike-in peptides as differences between groups. Tools that accurately identify the spike-in peptides are likely to be useful in biomarker discovery research.

Description

Two datasets were generated from five serum samples obtained from five healthy individuals. The first dataset was derived from the five serum samples mixed with known concentration of spike-in peptides. The second dataset was obtained from the five serum samples alone. In the first dataset, nine MassPrep peptides (Table 1). The concentration of the MassPrep peptides (1 pmol/Ál) was selected based on best detection of the lowest concentration of MassPrep peptides available on the Qstar instrument (data not shown). Both datasets were acquired by LC-MS/MS on the hybrid Q-TOF mass spectrometer using the same acquisition parameters.

Table 1: The sequence information of the nine selected MassPrep peptides.

Component Name Molecular Weight (g/mol) pKa Peptide Sequence
RASG-1 1000.4938 9.34 RGDSPASSKP
Angiotensin frag 1-7 898.4661 7.35 DRVYIHP
Bradykinin 1059.5613 12.00 RPPGFSPFR
Angiotensin II 1045.5345 7.35 DRVYIHPF
Angiotensin I 1295.6775 7.51 DRVYIHPFHL
Renin substrate 1757.9253 7.61 DRVYIHPFHLLVYS
Enolase T35 1871.9604 7.34 WLTGPQLADLYHSLMK
Enolase T37 2827.2806 3.97 YPIVSIEDPFAEDDWEAWSHFFK
Melitin 2845.7381 12.06 GIGAVLKVLTTGLPALISWIKRKRQQ

LC-MS dataset

Group 1: Serum with spike-in peptides data (404 MB)

Group 2: Serum alone data (404 MB)